GADDIEL SARMIENTO
- Type
- Non-physician practitioner · Physician Assistants & Advanced Practice Nursing Providers / Nurse Practitioner / Psychiatric/Mental Health
- Where
- BEAUMONT, CA
- NPI
- 1952174484
- Received
- $4,827 in 137 records, 2024 to 2025
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 105 | $3,406 |
| 2024 | General payment | 32 | $1,421 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| ABBVIE INC. | 56 | $1,657 | 2024–2025 |
| Otsuka America Pharmaceutical, Inc. | 17 | $667 | 2024–2025 |
| Janssen Pharmaceuticals, Inc | 8 | $624 | 2024–2025 |
| Vanda Pharmaceuticals Inc. | 14 | $482 | 2024–2025 |
| Teva Pharmaceuticals USA, Inc. | 15 | $341 | 2024–2025 |
| E.R. Squibb & Sons, L.L.C. | 3 | $318 | 2024–2025 |
| Alkermes, Inc. | 6 | $206 | 2025 |
| Novo Nordisk Inc | 1 | $131 | 2025 |
| Neurocrine BioSciences, Inc. | 5 | $125 | 2024–2025 |
| Almatica Pharma LLC | 6 | $109 | 2024–2025 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $74 | 2024–2025 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $47 | 2024 |
| Noven Therapeutics, LLC | 1 | $24 | 2024 |
| Lundbeck LLC | 1 | $17 | 2024 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Food and Beverage | 137 | $4,827 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-18 | Neurocrine BioSciences, Inc. | $17 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-12-01 | ABBVIE INC. | $22 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-11-20 | Teva Pharmaceuticals USA, Inc. | $24 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-11-19 | E.R. Squibb & Sons, L.L.C. | $109 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-11-19 | ABBVIE INC. | $32 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-11-14 | Janssen Pharmaceuticals, Inc | $26 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2025 | |
| 2025-11-13 | Otsuka America Pharmaceutical, Inc. | $24 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-11-06 | ABBVIE INC. | $20 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-11-05 | ABBVIE INC. | $25 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-10-30 | Alkermes, Inc. | $19 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-10-30 | Alkermes, Inc. | $3 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-10-29 | ABBVIE INC. | $27 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-10-23 | ABBVIE INC. | $33 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-10-20 | ABBVIE INC. | $33 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-10-18 | Alkermes, Inc. | $31 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-10-17 | Otsuka America Pharmaceutical, Inc. | $10 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-10-13 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-10-09 | Otsuka America Pharmaceutical, Inc. | $26 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-10-07 | ABBVIE INC. | $29 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-10-01 | ABBVIE INC. | $27 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-09-26 | Teva Pharmaceuticals USA, Inc. | $34 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-09-25 | ABBVIE INC. | $28 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-09-23 | ABBVIE INC. | $22 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-09-18 | Otsuka America Pharmaceutical, Inc. | $25 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-09-17 | Otsuka America Pharmaceutical, Inc. | $32 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-09-17 | ABBVIE INC. | $17 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-09-11 | Vanda Pharmaceuticals Inc. | $18 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-09-05 | Otsuka America Pharmaceutical, Inc. | $33 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-09-04 | Janssen Pharmaceuticals, Inc | $110 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2025 | |
| 2025-09-04 | Alkermes, Inc. | $21 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-09-03 | Otsuka America Pharmaceutical, Inc. | $121 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-08-29 | Teva Pharmaceuticals USA, Inc. | $13 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-08-22 | Janssen Pharmaceuticals, Inc | $32 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2025 | |
| 2025-08-21 | ABBVIE INC. | $21 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-08-19 | ABBVIE INC. | $28 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-08-13 | ABBVIE INC. | $27 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-08-11 | ABBVIE INC. | $28 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-08-05 | ABBVIE INC. | $33 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-07-31 | Vanda Pharmaceuticals Inc. | $22 | Food and Beverage | In-kind items and services | HETLIOZ Drug, NON-24-HOUR SLEEP-WAKE DISORDER | 2025 | |
| 2025-07-29 | ABBVIE INC. | $30 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-07-26 | ABBVIE INC. | $11 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-07-23 | ABBVIE INC. | $25 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-07-23 | Otsuka America Pharmaceutical, Inc. | $21 | Food and Beverage | In-kind items and services | ABILIFY ASIMTUFII Drug, PSYCHIATRY | 2025 | |
| 2025-07-19 | ABBVIE INC. | $21 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-07-16 | ABBVIE INC. | $32 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-07-14 | ABBVIE INC. | $34 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-07-12 | ABBVIE INC. | $21 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-07-10 | Almatica Pharma LLC | $27 | Food and Beverage | In-kind items and services | LOREEV XR Drug, ANTI-ANXIETY | 2025 | |
| 2025-07-03 | Vanda Pharmaceuticals Inc. | $14 | Food and Beverage | In-kind items and services | HETLIOZ Drug, NON-24-HOUR SLEEP-WAKE DISORDER | 2025 | |
| 2025-07-03 | ABBVIE INC. | $8 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-06-26 | Teva Pharmaceuticals USA, Inc. | $20 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-06-12 | Vanda Pharmaceuticals Inc. | $28 | Food and Beverage | In-kind items and services | HETLIOZ Drug, NON-24-HOUR SLEEP-WAKE DISORDER | 2025 | |
| 2025-06-12 | Almatica Pharma LLC | $15 | Food and Beverage | In-kind items and services | LOREEV XR Drug, ANTI-ANXIETY | 2025 | |
| 2025-06-10 | ABBVIE INC. | $24 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-06-05 | ABBVIE INC. | $24 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-06-05 | Otsuka America Pharmaceutical, Inc. | $23 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-06-05 | ABBVIE INC. | $18 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-06-05 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-05-31 | ABBVIE INC. | $30 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-05-30 | ABBVIE INC. | $22 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-05-30 | Vanda Pharmaceuticals Inc. | $13 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-05-29 | Otsuka America Pharmaceutical, Inc. | $125 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-05-23 | ABBVIE INC. | $31 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-05-22 | Janssen Pharmaceuticals, Inc | $114 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2025 | |
| 2025-05-21 | ABBVIE INC. | $18 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-05-14 | Novo Nordisk Inc | $131 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2025 | |
| 2025-05-14 | Almatica Pharma LLC | $22 | Food and Beverage | In-kind items and services | LOREEV XR Drug, ANTI-ANXIETY | 2025 | |
| 2025-05-13 | ABBVIE INC. | $27 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-05-10 | ABBVIE INC. | $30 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-05-09 | ABBVIE INC. | $18 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-05-08 | Vanda Pharmaceuticals Inc. | $22 | Food and Beverage | In-kind items and services | HETLIOZ Drug, NON-24-HOUR SLEEP-WAKE DISORDER | 2025 | |
| 2025-05-08 | ABBVIE INC. | $3 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-05-01 | ABBVIE INC. | $34 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-04-30 | E.R. Squibb & Sons, L.L.C. | $77 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-04-25 | Otsuka America Pharmaceutical, Inc. | $29 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-04-25 | ABBVIE INC. | $19 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-04-24 | Neurocrine BioSciences, Inc. | $26 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-04-22 | ABBVIE INC. | $32 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-04-17 | ABBVIE INC. | $121 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-04-17 | Otsuka America Pharmaceutical, Inc. | $27 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-04-17 | Alkermes, Inc. | $10 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-04-14 | ABBVIE INC. | $21 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-04-12 | Otsuka America Pharmaceutical, Inc. | $29 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-04-11 | Otsuka America Pharmaceutical, Inc. | $26 | Food and Beverage | In-kind items and services | ABILIFY ASIMTUFII Drug, PSYCHIATRY | 2025 | |
| 2025-04-10 | Vanda Pharmaceuticals Inc. | $15 | Food and Beverage | In-kind items and services | HETLIOZ Drug, NON-24-HOUR SLEEP-WAKE DISORDER | 2025 | |
| 2025-04-08 | ABBVIE INC. | $23 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-04-04 | ABBVIE INC. | $22 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-04-03 | ABBVIE INC. | $19 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-04-03 | ABBVIE INC. | $18 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-03-28 | ABBVIE INC. | $29 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-03-27 | Neurocrine BioSciences, Inc. | $29 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-03-21 | ABBVIE INC. | $30 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-03-19 | ABBVIE INC. | $125 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-03-14 | ABBVIE INC. | $18 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-03-11 | Alkermes, Inc. | $121 | Food and Beverage | In-kind items and services | LYBALVI Drug, CNS | 2025 | |
| 2025-03-11 | ABBVIE INC. | $28 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-03-08 | Vanda Pharmaceuticals Inc. | $28 | Food and Beverage | In-kind items and services | HETLIOZ Drug, NON-24-HOUR SLEEP-WAKE DISORDER | 2025 | |
| 2025-03-06 | Teva Pharmaceuticals USA, Inc. | $20 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-02-28 | Otsuka America Pharmaceutical, Inc. | $25 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-02-01 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-01-30 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $26 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-01-23 | Neurocrine BioSciences, Inc. | $27 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-01-09 | Vanda Pharmaceuticals Inc. | $14 | Food and Beverage | In-kind items and services | HETLIOZ Drug, NON-24-HOUR SLEEP-WAKE DISORDER | 2025 | |
| 2025-01-08 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $21 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-01-04 | ABBVIE INC. | $21 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2024-12-20 | Teva Pharmaceuticals USA, Inc. | $22 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2024 | |
| 2024-12-20 | Almatica Pharma LLC | $14 | Food and Beverage | In-kind items and services | LOREEV XR Drug, ANTI-ANXIETY | 2024 | |
| 2024-12-19 | Vanda Pharmaceuticals Inc. | $9 | Food and Beverage | In-kind items and services | HETLIOZ Drug, NON-24-HOUR SLEEP-WAKE DISORDER | 2024 | |
| 2024-12-06 | Lundbeck LLC | $17 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-12-05 | Almatica Pharma LLC | $14 | Food and Beverage | In-kind items and services | LOREEV XR Drug, ANTI-ANXIETY | 2024 | |
| 2024-11-22 | Almatica Pharma LLC | $15 | Food and Beverage | In-kind items and services | LOREEV XR Drug, ANTI-ANXIETY | 2024 | |
| 2024-11-21 | Janssen Pharmaceuticals, Inc | $12 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2024 | |
| 2024-11-20 | ABBVIE INC. | $125 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-11-09 | Teva Pharmaceuticals USA, Inc. | $21 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2024 | |
| 2024-11-07 | Teva Pharmaceuticals USA, Inc. | $17 | Food and Beverage | In-kind items and services | Austedo XR Drug, Central Nervous System | 2024 | |
| 2024-11-06 | E.R. Squibb & Sons, L.L.C. | $131 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Psychiatry/Psychology | 2024 | |
| 2024-10-26 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $26 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-10-18 | ABBVIE INC. | $24 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-10-11 | Teva Pharmaceuticals USA, Inc. | $14 | Food and Beverage | In-kind items and services | Austedo XR Drug, Central Nervous System | 2024 | |
| 2024-10-10 | Janssen Pharmaceuticals, Inc | $86 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2024 | |
| 2024-09-27 | Otsuka Pharmaceutical Development & Commercialization, Inc. | $47 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-08-23 | Vanda Pharmaceuticals Inc. | $20 | Food and Beverage | In-kind items and services | HETLIOZ Drug, NON-24-HOUR SLEEP-WAKE DISORDER | 2024 | |
| 2024-08-21 | Janssen Pharmaceuticals, Inc | $124 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2024 | |
| 2024-07-25 | Vanda Pharmaceuticals Inc. | $124 | Food and Beverage | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2024 | |
| 2024-06-28 | Neurocrine BioSciences, Inc. | $23 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2024 | |
| 2024-06-27 | Teva Pharmaceuticals USA, Inc. | $21 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2024 | |
| 2024-06-26 | Janssen Pharmaceuticals, Inc | $116 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2024 | |
| 2024-06-21 | Teva Pharmaceuticals USA, Inc. | $26 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2024 | |
| 2024-06-20 | Vanda Pharmaceuticals Inc. | $125 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2024 | |
| 2024-06-14 | Teva Pharmaceuticals USA, Inc. | $17 | Food and Beverage | In-kind items and services | Austedo XR Drug, Central Nervous System | 2024 | |
| 2024-06-07 | Teva Pharmaceuticals USA, Inc. | $33 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2024 | |
| 2024-06-07 | Vanda Pharmaceuticals Inc. | $24 | Food and Beverage | In-kind items and services | HETLIOZ Drug, NON-24-HOUR SLEEP-WAKE DISORDER | 2024 | |
| 2024-05-31 | Teva Pharmaceuticals USA, Inc. | $20 | Food and Beverage | In-kind items and services | Austedo XR Drug, Central Nervous System | 2024 | |
| 2024-05-23 | Teva Pharmaceuticals USA, Inc. | $32 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2024 | |
| 2024-04-02 | Noven Therapeutics, LLC | $24 | Food and Beverage | In-kind items and services | Xelstrym Drug, ADHD | 2024 | |
| 2024-04-02 | Otsuka America Pharmaceutical, Inc. | $19 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-01-25 | Otsuka America Pharmaceutical, Inc. | $64 | Food and Beverage | In-kind items and services | ABILIFY MAINTENA Drug, PSYCHIATRY | 2024 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Beaumont, CA, county Riverside County, CA, state California; placed by its city name.
| Measure | Place (city or town) Beaumont, CA | County Riverside County, CA | State California |
|---|---|---|---|
| Population B01003 | 56,266 | 2,478,600 | 39,287,377 |
| Population, 2020 census P1 | 53,036 | 2,418,185 | 39,538,223 |
| Median age B01002 | 35.5 | 37.0 | 37.9 |
| Under 18 B01001 | 29.5% | 24.1% | 22.0% |
| 65 and over B01001 | 15.1% | 15.4% | 15.7% |
| Households B11001 | 17,721 | 775,335 | 13,548,091 |
| Foreign born B05002 | 14.1% | 21.9% | 27.0% |
| Median household income B19013 | $107,118 | $93,074 | $99,122 |
| Median family income B19113 | $115,578 | $103,984 | $113,346 |
| Per capita income B19301 | $38,913 | $38,317 | $49,513 |
| Poverty rate B17001 | 10.0% | 10.6% | 12.0% |
| Unemployment rate B23025 | 4.9% | 6.5% | 6.6% |
| Civilian labor force B23025 | 25,881 | 1,191,323 | 20,068,466 |
| Mean commute (minutes) B08013 | 35.7 | 33.8 | 28.7 |
| Bachelor's degree or higher B15003 | 27.4% | 25.6% | 37.1% |
| Housing units B25001 | 18,044 | 869,414 | 14,644,735 |
| Owner-occupied B25003 | 80.8% | 69.1% | 55.9% |
| Renters B25003 | 19.2% | 30.9% | 44.1% |
| Median home value B25077 | $503,500 | $557,300 | $734,700 |
| Median gross rent B25064 | $1,681 | $1,901 | $2,036 |
| White, not Hispanic B03002 | 33.8% | 31.0% | 33.8% |
| Black B03002 | 8.1% | 6.0% | 5.2% |
| Hispanic or Latino B03002 | 46.8% | 51.3% | 40.2% |
| Asian B03002 | 6.8% | 6.9% | 15.3% |
| American Indian and Alaska Native B03002 | 0.5% | 0.3% | 0.3% |
Economy now FRED unemployment 5.1% in Sep 2026 (5.5% a year earlier); per capita personal income $90,957 in 2025, up 30% in five years (+4.3% after inflation); the state; Source: FRED, Federal Reserve Bank of St. Louis.
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Beaumont, CA.
Comments